Novanta Inc. NOVT
147.49 USD +1.25 (+0.85%)
At closeNov 3, 2026, 4:03 PM EST
147.49 0.00 0.00%
After hours · Nov 3, 4:03 PM ET
146.99 Day range 150.54
98.27 52-week range 176.38
- YTD
- +23.95%
- 1 year
- +8.56%
News
etftrends.com Human Data, Robot Hands: Where Automation Goes Next High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.
gurufocus.com Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026 Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Rober
businesswire.com Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026 BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley,…
etftrends.com How to Invest in AI Drug Discovery .Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to…
businesswire.com Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026…
benzinga.com Here's How Much $100 Invested In Novanta 15 Years Ago Would Be Worth Today Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.15% on an annualized basis producing an average annual return of 20.4%. Currently, Novanta has a market capitalization of…
defenseworld.net Eltek (NASDAQ:ELTK) vs. Novanta (NASDAQ:NOVT) Financial Survey Eltek (NASDAQ: ELTK - Get Free Report) and Novanta (NASDAQ: NOVT - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the…
benzinga.com Here’s How Much You Would Have Made Owning Novanta Stock In The Last 15 Years Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 8.22% on an annualized basis producing an average annual return of 21.59%. Currently, Novanta has a market capitalization…
defenseworld.net Analyzing Senstar Technologies (NASDAQ:SNT) and Novanta (NASDAQ:NOVT) Novanta (NASDAQ: NOVT - Get Free Report) and Senstar Technologies (NASDAQ: SNT - Get Free Report) are both technology companies, but which is the superior business? We will compare the two businesses…
etftrends.com How to Build a Humanoid Body Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.
benzinga.com $1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.74% on an annualized basis producing an average annual return of 21.09%. Currently, Novanta has a market capitalization…
zacks.com Are Robots the New Normal? Bet on these ETFs to Invest in the Future Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
defenseworld.net Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Novanta Inc. $NOVT Connor Clark and Lunn Investment Management Ltd. acquired a new position in Novanta Inc. (NASDAQ: NOVT) in the second quarter, according to its most recent 13F filing with the Securities and Exchange…
businesswire.com Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026 BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley,…- benzinga.com Here’s How Much You Would Have Made Owning Novanta Stock In The Last 10 Years Novanta (NASDAQ:NOVT) has outperformed the market over the past 10 years by 10.52% on an annualized basis producing an average annual return of 23.93%. Currently, Novanta has a market capitalization…
zacks.com Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price…- benzinga.com $1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.55% on an annualized basis producing an average annual return of 21.3%. Currently, Novanta has a market capitalization of…
zacks.com Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
defenseworld.net Novanta Inc. $NOVT Shares Bought by Bank of America Corp DE Bank of America Corp DE increased its stake in Novanta Inc. (NASDAQ: NOVT) by 18.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission…
defenseworld.net Amundi Purchases 3,516 Shares of Novanta Inc. $NOVT Amundi increased its position in shares of Novanta Inc. (NASDAQ: NOVT) by 17.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor…
defenseworld.net Novanta Q2 Earnings Call Highlights Novanta (NASDAQ: NOVT) reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July…
marketbeat.com Novanta Q2 Earnings Call Highlights Novanta NASDAQ: NOVT reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July…
seekingalpha.com Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript
zacks.com Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates Novanta (NOVT) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.76 per share a year ago.
benzinga.com Novanta Raises FY2026 Adj EPS Guidance from $3.50-$3.65 to $3.68-$3.74 vs $3.59 Est; Raises FY2026 Sales Guidance from $1.040B-$1.055B to $1.130B-$1.140B vs $1.053B Est Novanta (NASDAQ:NOVT) raises FY2026 Adj EPS guidance from $3.50-$3.65 to $3.68-$3.74 vs $3.59 analyst estimate. Raises FY2026 sales outlook from $1.040 billion-$1.055 billion to $1.130 billion-$1.140…
benzinga.com Novanta Sees Q3 Adj EPS $0.95-$1.00 vs $0.94 Est; Sees Sales $300.000M-$304.000M vs $262.827M Est Novanta (NASDAQ:NOVT) is looking for Q3 Adj EPS of $0.95-$1.00 vs $0.94 analyst estimate. sees sales of $300.000 million-$304.000 million vs $262.827 million analyst estimate.
benzinga.com Novanta Q2 Adj. EPS $0.89 Beats $0.83 Estimate, Sales $265.807M Beat $262.297M Estimate Novanta (NASDAQ:NOVT) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.83 by 7.23 percent. This is a 17.11 percent increase over earnings of $0.76 per…
businesswire.com Novanta Announces Financial Results for the Second Quarter 2026 BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial…
benzinga.com Novanta Prices ~$300M Private Placement Of 2,142,857 Shares At $140 Per Share Novanta Inc. ("Novanta" or the "Company") announced today that it has entered into a securities purchase agreement for a private placement of the Company's common shares ("Common Shares") to…
benzinga.com Novanta Acquires Maker Of Minimally Invasive Surgical Consumables Riverpoint Medical For $1.45B In Cash From Arlington Capital Partners Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today announced that it has…
benzinga.com Baird Maintains Outperform on Novanta, Raises Price Target to $173 Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Outperform and raises the price target from $144 to $173.
benzinga.com Novanta Q1 2026 Earnings Call Transcript - benzinga.com Novanta Affirms FY2026 Adj EPS Guidance of $3.50-$3.65 vs $3.56 Est; Raises FY2026 Sales Guidance from $1.030B-$1.050B to $1.040B-$1.055B vs $1.045B Est. Novanta (NASDAQ:NOVT) affirms FY2026 Adj EPS guidance from $3.50-$3.65 to $3.50-$3.65 vs $3.56 analyst estimate. Raises FY2026 sales outlook from $1.030 billion-$1.050 billion to $1.040…
- benzinga.com Novanta Sees Q2 Adj EPS $0.81-$0.86 vs $0.86 Est; Sees Sales $259.000M-$264.000M vs $257.083M Est. Novanta (NASDAQ:NOVT) is looking for Q2 Adj EPS of $0.81-$0.86 vs $0.86 analyst estimate. sees sales of $259.000 million-$264.000 million vs $257.083 million analyst estimate.
- benzinga.com Novanta Q1 Adj. EPS $0.81 Beats $0.78 Estimate, Sales $257.707M Beat $253.393M Estimate. Novanta (NASDAQ:NOVT) reported quarterly earnings of $0.81 per share which beat the analyst consensus estimate of $0.78 by 3.85 percent. This is a 9.46 percent increase over earnings of $0.74 per…
benzinga.com Earnings Scheduled For May 11, 2026 
benzinga.com Baird Upgrades Novanta to Outperform, Lowers Price Target to $144 Baird analyst Robert Mason upgrades Novanta (NASDAQ:NOVT) from Neutral to Outperform and lowers the price target from $150 to $144.
benzinga.com 10 Information Technology Stocks Whale Activity In Today's Session - benzinga.com Novanta Sees Q1 Adj EPS $0.75-$0.80 vs $0.83 Est; Sees Sales $250.000M-$255.000M vs $516.953M Est Novanta (NASDAQ:NOVT) is looking for Q1 Adj EPS of $0.75-$0.80 vs $0.83 analyst estimate. sees sales of $250.000 million-$255.000 million vs $516.953 million analyst estimate.
- benzinga.com Novanta Sees FY2026 Adj EPS $3.50-$3.65 vs $3.61 Est; Sees Sales $1.030B-$1.050B vs $1.043B Est Novanta (NASDAQ:NOVT) is looking for FY2026 Adj EPS of $3.50-$3.65 vs $3.61 analyst estimate. sees sales of $1.030 billion-$1.050 billion vs $1.043 billion analyst estimate.
- benzinga.com Novanta Q4 Adj. EPS $0.91 Beats $0.88 Estimate, Sales $258.349M Beat $255.560M Estimate Novanta (NASDAQ:NOVT) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.88 by 3.41 percent. This is a 19.74 percent increase over earnings of $0.76 per…
benzinga.com A Preview Of Novanta's Earnings - benzinga.com Novanta Raises $533M Through $50-Per-Unit Public Equity Offering to Strengthen Balance Sheet and Fund Growth Plans Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has priced its previously…
benzinga.com Novanta Commences $550M Offering Of 11M Tangible Equity Units At $50/Unit Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has commenced a public…- benzinga.com Novanta Narrows FY2025 Adj EPS Guidance from $3.22-$3.36 to $3.24-$3.30 vs $3.26 Est; Narrows FY2025 Sales Guidance from $970.000M-$985.000M to $975.000M-$979.000M vs $977.747M Est Novanta (NASDAQ:NOVT) narrows FY2025 Adj EPS guidance from $3.22-$3.36 to $3.24-$3.30 vs $3.26 analyst estimate. Narrows FY2025 sales outlook from $970.000 million-$985.000 million to $975.000…
- benzinga.com Novanta Sees Q4 Adj EPS $0.87-$0.93 vs $0.94 Est; Sees Sales $253.000M-$257.000M vs $255.160M Est Novanta (NASDAQ:NOVT) is looking for Q4 Adj EPS of $0.87-$0.93 vs $0.94 analyst estimate. sees sales of $253.000 million-$257.000 million vs $255.160 million analyst estimate.
- benzinga.com Novanta Q3 Adj. EPS $0.87 Beats $0.82 Estimate, Sales $247.836M Beat $245.950M Estimate Novanta (NASDAQ:NOVT) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.82 by 6.49 percent. This is a 2.35 percent increase over earnings of $0.85 per…
- benzinga.com 12 Information Technology Stocks Moving In Wednesday's After-Market Session
- benzinga.com Novanta Board Authorizes Repurchase Of Up To Addl. $200M Of Outstanding Common Shares, Adding Capacity To $31M Remaining From 2020 Board Authorization, For Total Capacity Of $231M Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the…
- benzinga.com Baird Maintains Neutral on Novanta, Lowers Price Target to $133 Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Neutral and lowers the price target from $139 to $133.